The global clarithromycin tablets market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to fuel the market growth include the increased count of skin and bacterial infections, R&D investments and collaboration, the sources which cause bacterial infection, clarithromycin drugs used to treat cancer, which are initiating the repurposing drugs in oncology projects. Clarithromycin tablets are used to treat bacterial infections. This drug can also be used in combination with anti-ulcer medications to treat types of stomach ulcers caused by helicobacter pylori.
Clarithromycin Tablets are also used for treating pneumonia, bronchitis, and infections of the ears, sinuses, skin, and throat. It is commonly known as a macrolide antibiotic. These tablets are available under the following different brand names: Biaxin, and Biaxin XL. Moreover, the escalated growth of skin and bacterial infections is driving the market growth. A bacterial infection is the propagation of harmful strains of bacteria inside the body. According to the Centre for Disease Control and Prevention, more than 2.8 million antibiotic-resistant contaminations occur in the US each year. The death toll is more than 35,000. In 2017, 223,900 cases of Clostridiodes difficile occurred. The sources of bacterial infection are also boosting the market growth, such as bacterial transmission, environment, consuming contaminated food and water, self-infection, person to person, or medical surgeries.
Market Coverage
Competitive Landscape: Abbvie Inc., Abbott Laboratories, and Apotex Inc., among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Clarithromycin Tablets Market Report Segmentation
By Product Type
• 250 MG
• 500 MG
By Application
• Dermatology
• CVD
• Thoracic
• Pediatric
• ENT
Global Clarithromycin Tablets Market by Region
North America
Europe
Asia-Pacific